Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,596 across all filing types
Latest filing 2025-06-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（赖瀚琪）
Board/Management Information Classification · 100% confidence The document is a detailed declaration and commitment statement by an independent director candidate for a company's board. It includes multiple attestations about qualifications, independence, compliance with laws and regulations, and commitments to fulfill duties. There is no financial data, no report of financial results, no voting results, no meeting materials, and no mention of any report publication. The content is focused on board/management information specifically related to the nomination and qualifications of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is not an announcement of a report publication or a certification letter; it is a formal declaration related to board membership.
2025-06-30 Chinese
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 100% confidence The document is titled as a remuneration management system for directors and senior management of a company. It details the principles, management structure, standards, payment, adjustment, and other rules related to compensation for directors and senior executives. There is no financial data, earnings information, or regulatory filing content. The content is focused on compensation policies and governance related to remuneration. This matches the definition of Remuneration Information (DEF 14A), which covers reports detailing compensation for top executives and directors.
2025-06-30 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management System" for a company, detailing principles, content, organization, and implementation of investor relations management. It focuses on governance, communication with investors, compliance with laws, and procedures for managing investor relations. There are no financial statements, earnings data, or audit information. It is a governance-related document outlining internal rules and practices for investor relations management. It is not a report, announcement, or transcript. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 4465 characters, which is substantive and not a brief announcement or certification.
2025-06-30 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Board of Directors" of 特一药业集团股份有限公司. It details the composition, powers, meeting procedures, committees, and decision-making processes of the company's board of directors. There is no financial data, no mention of financial results, no audit report, no voting results, no announcements of report publications, or any other regulatory filings. The content is focused on governance structure and internal rules of the board. Therefore, this document fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-06-30 Chinese
股东会议事规则
Governance Information Classification · 95% confidence The document is titled as "股东会议事规则" which translates to "Shareholders Meeting Rules" or "Rules of Procedure for Shareholders' Meetings" for 特一药业集团股份有限公司. It extensively details the procedures, rules, and regulations governing the convening, notification, proposal submission, voting, and conduct of shareholders' meetings. It references relevant laws and regulations such as the Company Law, Securities Law, and the company's Articles of Association. The content is focused on governance and procedural rules rather than financial results, audit opinions, or announcements of meetings or voting results. It is not a report of an actual meeting, nor an announcement of voting results, nor a presentation or financial report. It is a governance document outlining internal rules and practices related to shareholder meetings. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7037 characters) and detailed procedural content support this classification with high confidence.
2025-06-30 Chinese
董事会提名委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the "Board Nomination Committee Working Rules" of a company, detailing the structure, responsibilities, procedures, and governance of the board nomination committee. It is a governance-related internal regulation document, not a financial report, announcement, or meeting material. It does not contain financial data, voting results, or executive changes. It is a governance information document outlining internal rules and board structure.
2025-06-30 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.